Ian Ragan

Ian Ragan is a seasoned professional with a diverse background in healthcare and research.

He currently serves as the Director at the National Autism Project, showcasing his dedication to autism advocacy and support.

Ragan has a rich history of advisory roles, having been part of the Advisory Boards at the Digital Health Forum and the Centre for Biological Sciences at the University of Southampton.

His significant contributions extend to organizations like the National Centre for the 3Rs and the Independent Scientific Committee on Drugs, where he served as a Board Member.

Ragan's expertise also includes directorial positions at Cir Consulting and Psynova Neurotech Ltd, demonstrating his leadership skills and strategic acumen.

Furthermore, he has experience in coordinating projects, as seen during his tenure as the Project Co-Ordinator at the European Partnership for Alternative Approaches to Animal Testing.

Ragan's involvement in the healthcare sector is evident through his role as a Member of the External Advisory Board at Biovail and his executive positions at Eli Lilly and Company and Merck, where he led divisions focused on neuroscience research, biochemistry, and molecular biology.

His commitment to neurology and brain research is highlighted by his role as the Executive Director at the European Brain Council and his trusteeship at Autistica.

Through his various appointments and affiliations, Ian Ragan has established himself as a respected figure in the field, known for his expertise, strategic insights, and dedication to advancing healthcare and research initiatives.